Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Calliditas Therapeutics AB publ stock

Learn how to easily invest in Calliditas Therapeutics AB publ stock.

Calliditas Therapeutics AB (publ) is a biotechnology business based in the US. Calliditas Therapeutics AB publ shares (CALT) are listed on the NASDAQ and all prices are listed in US Dollars. Calliditas Therapeutics AB publ employs 65 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Calliditas Therapeutics AB publ

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CALT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Calliditas Therapeutics AB publ stock price (NASDAQ: CALT)

Use our graph to track the performance of CALT stocks over time.

Calliditas Therapeutics AB publ shares at a glance

Information last updated 2022-01-10.
Latest market close$23.17
52-week range$14.22 - $33.19
50-day moving average $19.92
200-day moving average $25.38
Wall St. target price$63.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Calliditas Therapeutics AB publ shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
$125 - $625
Open and fund an account with $25,000 - $250,000+

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Calliditas Therapeutics AB publ stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Calliditas Therapeutics AB publ price performance over time

Historical closes compared with the close of $23.17 from 2022-01-14

1 week (2022-01-07) -0.26%
1 month (2021-12-16) 1.05%
3 months (2021-10-15) 4.46%
6 months (2021-07-16) -21.48%
1 year (2021-01-15) -23.02%
2 years (2020-01-12) N/A
3 years (2019-01-12) N/A
5 years (2017-01-12) N/A

Calliditas Therapeutics AB publ financials

Gross profit TTM $874,000
Return on assets TTM -16.85%
Return on equity TTM -34.26%
Profit margin -224.05%
Book value N/A
Market capitalisation $609.8 million

TTM: trailing 12 months

Calliditas Therapeutics AB publ share dividends

We're not expecting Calliditas Therapeutics AB publ to pay a dividend over the next 12 months.

Calliditas Therapeutics AB publ share price volatility

Over the last 12 months, Calliditas Therapeutics AB publ's shares have ranged in value from as little as $14.22 up to $33.19. A popular way to gauge a stock's volatility is its "beta".

CALT.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Calliditas Therapeutics AB publ's is 1.4517. This would suggest that Calliditas Therapeutics AB publ's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Calliditas Therapeutics AB publ overview

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. The company's lead product candidate is Nefecon, a oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease IgA nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden. .

Frequently asked questions

What percentage of Calliditas Therapeutics AB publ is owned by institutions?
Currently 3.691% of Calliditas Therapeutics AB publ shares are held by institutions.
How many people work for Calliditas Therapeutics AB publ?
Latest data suggests 65 work at Calliditas Therapeutics AB publ.
When does the fiscal year end for Calliditas Therapeutics AB publ?
Calliditas Therapeutics AB publ's fiscal year ends in December.
Where is Calliditas Therapeutics AB publ based?
Calliditas Therapeutics AB publ's address is: Kungsbron 1, C8, Stockholm, Sweden, 111 22
What is Calliditas Therapeutics AB publ's ISIN number?
Calliditas Therapeutics AB publ's international securities identification number is: US13124Q1067

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site